Study with Implantable "Telescope" Underway

Dr. David Boyer with Retina-Vitreous Associates Medical Group and Dr. Samuel Masket with Advanced Vision Careare participating in a nationwide, post-approval study of an implantable telescope, says a press release from the two practices. The device, developed by Dr. Isaac Lipshitz, has been approved by the FDA to improve vision for people living with end-stage age-related macular degeneration (AMD), according to Masket and Boyer.  The study reportedly will corroborate the safety data submitted to the FDA that led to approval and evaluate the patient care program in a commercial setting. Patients wishing to participate should contact one of the two practices. Read more.

First Patient Gets Implantable Telescope

The first patient has received the FDA-approved implantable miniature telescope for the treatment of end-stage age-related macular degeneration (AMD), according to a press release from CenteraSigh. The first patient's ophthalmologists were Henry L. Hudson, M.D., retinal specialist at Retina Centers, P.C., and Kristin Carter, M.D., anterior segment eye surgeon, both part of the CentraSigh provider team in Tucson. The procedure was performed on an outpatient basis at Carondelet Health Network's St. Joseph's Hospital in Tucson. It launches VisionCare's CentraSight AMD treatment program, which utilizes the implant for treating patients with advanced forms and stages of AMD. Read more.